JGJules Garreau

Jules Garreau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jules Garreau has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Anne Camus

    Nantes Université, Oniris, CHU Nantes, Inserm, Regenerative Medicine and Skeleton, RMeS, UMR 1229, 44000 Nantes, France

    1 shared publication
  • Ariane Mahieux

    Université de Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, ERL U1305, F-35000 Rennes, France

    1 shared publication
  • Christèle Dubourg

    Service de Génétique Moléculaire et Génomique, CHU Rennes, Université de Rennes, CNRS, INSERM, IGDR, UMR 6290, Rennes, France

    1 shared publication
  • Emmanuelle Jullion

    Université de Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, ERL U1305, F-35000 Rennes, France

    1 shared publication
  • Farah Diab

    Sorbonne Université, INSERM, Paris, France

    1 shared publication
  • Hélène Guyodo

    Université de Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, ERL U1305, F-35000 Rennes, France

    1 shared publication

Latest Publications

  • Open Access

    Mapping the temporal and functional landscape of Sonic Hedgehog signaling reveals new insights into early human forebrain development

    by Veranika Panasenkava, Jules Garreau, Hélène Guyodo, Farah Diab, Ariane Mahieux, Wilfrid Carré, Yann Verres, Emmanuelle Jullion, Sylvie Odent, Christèle Dubourg, et al.

    SUMMARY: The early patterning of the anterior neuroectoderm constitutes a fundamental blueprint for human brain development, orchestrated by multiple signaling pathways. Among them, Sonic Hedgehog (SHH) plays a key influence. However, the transcriptional programs it engages remain poorly defined due to the limited accessibility of human brain tissue. To address this, we established a human induced pluripotent stem cells-derived model of early forebrain differentiation, enabling a precise dissection of SHH-driven transcriptional programs over time. RNA sequencing revealed dynamic transcriptomic landscapes governing forebrain neuroectoderm specification and dorsoventral patterning. In addition, pharmacological perturbation of SHH signaling allowed to identify an extended collection of novel forebrain regionalization markers, including several previously unrecognized dorsal and ventral determinants. By combining in vivo human datasets with functional mouse studies, we enhanced the biological relevance of this extended network of putative SHH-regulated genes and long non-coding RNAs in shaping early forebrain architecture. This work advances our understanding of the temporal dynamics of SHH signaling in human neurodevelopment and provide critical molecular insights into midline brain malformations. It offers a promising foundation for advancing molecular diagnosis of complex rare genetic disorders. GRAPHICAL